Scholarlink

Background <p>This study aims to investigate the role of LINC01127 in sepsis and evaluate its potential clinical value.</p> Methods <p>This study included 102 sepsis patients and 102 controls matched for age and gender. Serum levels of LINC01127 and miR-34b-5p were measured using quantitative real-time PCR (RT-qPCR). Receiver operating characteristic (ROC) curves were constructed to assess the diagnostic efficacy of LINC01127 for sepsis, while Kaplan-Meier curves evaluated its prognostic significance during 28-day follow-up. Lipopolysaccharide (LPS)-induced THP-1 cells were used to simulate an in vitro sepsis model. Enzyme-linked immunosorbent assay (ELISA) measured proinflammatory factor levels, and flow cytometry assessed apoptosis.</p> Results <p>Serum LINC01127 exhibited downregulation in sepsis-affected individuals, while miR-34b-5p was upregulated. ROC curve analysis demonstrated that LINC01127 possesses good diagnostic value for sepsis. Kaplan-Meier analysis showed that low LINC01127 levels were associated with poorer prognosis during the 28-day follow-up. Bioinformatics analysis successfully predicted a binding site for miR-34b-5p on LINC01127, and dual-luciferase reporter (DLR) and RNA immunoprecipitation (RIP) assays confirmed their target relationship. Cell experiments demonstrated that upregulating LINC01127 significantly reduced the apoptosis and inflammation triggered by LPS, while increasing miR-34b-5p expression markedly reversed these effects.</p> Conclusion <p>LINC01127 may serve as a promising biomarker for sepsis, alleviating apoptosis and inflammatory responses through targeting miR-34b-5p. This offers novel insights into sepsis diagnosis and treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Serum LINC01127 serves as a diagnostic biomarker for sepsis and its predictive value for clinical outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月6日

查看全文
  • Congcong Li,
  • Xiao Gui,
  • Haiyuan Zhu,
  • Jinhui Wang,
  • Yu Xie,
  • Lilin Wang,
  • Yongyang Tian,
  • Shun Li

摘要

Background

This study aims to investigate the role of LINC01127 in sepsis and evaluate its potential clinical value.

Methods

This study included 102 sepsis patients and 102 controls matched for age and gender. Serum levels of LINC01127 and miR-34b-5p were measured using quantitative real-time PCR (RT-qPCR). Receiver operating characteristic (ROC) curves were constructed to assess the diagnostic efficacy of LINC01127 for sepsis, while Kaplan-Meier curves evaluated its prognostic significance during 28-day follow-up. Lipopolysaccharide (LPS)-induced THP-1 cells were used to simulate an in vitro sepsis model. Enzyme-linked immunosorbent assay (ELISA) measured proinflammatory factor levels, and flow cytometry assessed apoptosis.

Results

Serum LINC01127 exhibited downregulation in sepsis-affected individuals, while miR-34b-5p was upregulated. ROC curve analysis demonstrated that LINC01127 possesses good diagnostic value for sepsis. Kaplan-Meier analysis showed that low LINC01127 levels were associated with poorer prognosis during the 28-day follow-up. Bioinformatics analysis successfully predicted a binding site for miR-34b-5p on LINC01127, and dual-luciferase reporter (DLR) and RNA immunoprecipitation (RIP) assays confirmed their target relationship. Cell experiments demonstrated that upregulating LINC01127 significantly reduced the apoptosis and inflammation triggered by LPS, while increasing miR-34b-5p expression markedly reversed these effects.

Conclusion

LINC01127 may serve as a promising biomarker for sepsis, alleviating apoptosis and inflammatory responses through targeting miR-34b-5p. This offers novel insights into sepsis diagnosis and treatment.